UNFAIR BUSINESS PRACTICES
 

Class Action Suit Filed Against
SmithKlineBeecham

Shapiro Haber & Urmy is serving as liaison counsel in this antitrust action against SmithKilneBeecham with respect to its brand name drug Relafen. The complaint alleges that defendants fraudulently obtained patents for Relafen and then wrongfully used these invalid patents to wrongfully block competitors from introducing generic competition for Relafen. The case is pending in the United States District Court for the District of Massachusetts.